6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor

Autor:	M Romero-González, J Cordero Ramos, M Valera Rubio, V Merino Bohorquez, L Martin Casado
Rok vydání:	2023
Zdroj:	Section 6: Education and research.
DOI:	10.1136/ejhpharm-2023-eahp.347
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::19b5ca81371070688c90eed45363e39f https://doi.org/10.1136/ejhpharm-2023-eahp.347 Zobrazit plný text záznamu